{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:20:58Z","timestamp":1787721658683,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite the development of advanced therapeutic approaches in the last two decades, acute myeloid leukemia (AML) has a poor prognosis, especially in older patients. The main causes of death are refractory\/relapsed disease, fatal bleeding, or serious infection. A model to predict survival in patients with AML is necessary for clinicians to make decisions regarding appropriate treatment. In this study, we aimed to evaluate the predictive factors for death and generate a model to predict survival in patients with AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter prospective cohort study across nine tertiary medical care institutes in Thailand, enrolling patients aged \u2265 18 years with newly diagnosed AML between January 1, 2014, and December 31, 2023. Patients with acute promyelocytic leukemia were excluded. Multivariable Cox proportional hazards regression analyses identified the predictors of mortality, and the final model was constructed using backward stepwise regression with Akaike Information Criterion selection. Model performance was assessed using Harrell\u2019s C-index and calibration plots, with internal validation performed via bootstrapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,055 patients were included. The median overall survival was 10.9 months, with a 10-year survival rate of 22.4%. Eight variables were independently associated with survival outcomes: age &amp;gt; 55 years, Eastern Cooperative Oncology Group performance status, tumor lysis syndrome, leukostasis, disseminated intravascular coagulation, white blood cell count, genetic risk, and type of induction therapy. The THAI-LEDGE model demonstrated a good discriminatory ability (C-index = 0.743) and satisfactory calibration. The internal validation yielded a C-index of 0.737, confirming the robustness of the model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The THAI-LEDGE model performed well in predicting the survival of AML patients. However, external validation of the model in other ethnic populations and healthcare settings are necessary before widespread clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1901725","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:50:10Z","timestamp":1787719810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction model for survival outcome in patients with acute myeloid leukemia: a multicenter prospective cohort study from Thai Acute Leukemia Working Group"],"prefix":"10.3389","volume":"16","author":[{"given":"Pirun","family":"Saelue","sequence":"first","affiliation":[{"name":"Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University","place":["Songkhla, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[{"name":"Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University","place":["Songkhla, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smith","family":"Kungwankiattichai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantiya","family":"Chanswangphuwana","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital","place":["Bangkok, Thailand"]},{"name":"Research Unit in Translational Hematology, Chulalongkorn University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital","place":["Bangkok, Thailand"]},{"name":"Research Unit in Translational Hematology, Chulalongkorn University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasithep","family":"Limvorapitak","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Thammasat University","place":["Pathumthani, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supawee","family":"Saengboon","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Thammasat University","place":["Pathumthani, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannadit","family":"Prayongratana","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantrapa","family":"Sriswasdi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teeraya","family":"Puavilai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chajchawan","family":"Nakhakes","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Rajavithi Hospital","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinadol","family":"Wanitpongpun","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Internal Medicine, Srinagarind Hospital, Khon Kaen University","place":["Khon Kaen, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia","volume":"361","author":"Fernandez","year":"2009","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.05.013","article-title":"Hypomethylating agents in the treatment of acute myeloid leukemia: a guide to optimal use","volume":"140","author":"Santini","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102549","article-title":"Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001\u20132019","volume":"71","author":"Linet","year":"2024","journal-title":"EClinicalmedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lrr.2016.06.001","article-title":"Acute myeloid leukemia in the older adults","volume":"6","author":"Almeida","year":"2016","journal-title":"Leuk Res Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225409","article-title":"Treatment of acute myeloid leukemia in older adults","volume":"15","author":"Alsouqi","year":"2023","journal-title":"Cancers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1270754","article-title":"Hyperleukocytosis and leukostasis: management of a medical emergency","volume":"10","author":"Giammarco","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017808","article-title":"How I treat AML incorporating the updated classifications and guidelines","volume":"141","author":"El Chaer","year":"2023","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017015222","article-title":"Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission","volume":"2","author":"Vasu","year":"2018","journal-title":"Blood Adv"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-017-0456-2","article-title":"Treatment of relapsed\/refractory acute myeloid leukemia","volume":"18","author":"Bose","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4236\/jbm.2021.910011","article-title":"Disseminated intravascular coagulation at diagnosis in acute myeloblastic leukaemia","volume":"9","author":"Chowdhury","year":"2021","journal-title":"J Biosci Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e18511","article-title":"Predictors of disseminated intravascular coagulation in patients with acute myeloid leukemia with severe sepsis and septic shock","volume":"42","author":"Adla Jala","year":"2024","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4245","article-title":"Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group","volume":"27","author":"B\u00fcchner","year":"2009","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2731","article-title":"Acute myeloid leukemia and myelodysplastic syndromes in older patients","volume":"25","author":"Estey","year":"2007","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.14.1597","article-title":"The outcomes and costs of acute myeloid leukemia among the elderly","volume":"162","author":"Menzin","year":"2002","journal-title":"Arch Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.234","article-title":"Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study","volume":"29","author":"\u00d8stg\u00e5rd","year":"2015","journal-title":"Leukemia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/10428190109097677","article-title":"Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival","volume":"42","author":"Giles","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-551507","article-title":"How I treat hyperleukocytosis in acute myeloid leukemia","volume":"125","author":"R\u00f6llig","year":"2015","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102310","article-title":"Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments","volume":"9","author":"Bewersdorf","year":"2020","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.9.1364","article-title":"Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival","volume":"5","author":"Dutcher","year":"1987","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21418","article-title":"Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis","volume":"84","author":"Piccirillo","year":"2009","journal-title":"Am J Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3324\/haematol.11575","article-title":"Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model","volume":"93","author":"Montesinos","year":"2008","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.02.017","article-title":"The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia","volume":"236","author":"Paterno","year":"2024","journal-title":"Thromb Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1901725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:50:21Z","timestamp":1787719821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1901725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1901725"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1901725","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1901725"}}